Skip to main content

Table 7 Subgroup analyses on the impacts of expenditures (thousand CNY)

From: The impact of the national volume-based procurement policy on the use of policy-related drugs in Nanjing: an interrupted time-series analysis

Categories

Drugs under the same generic name

Alternative drugs

Bid-winning

Generic

Branded

Total

Perfect

Fundamental

Limited

Total

ATC-C

 Level change

534.53

-7054.82***

-16,600.00***

-18,900.00**

425.88

-130.16

-565.91

-252.83

 Trend change

1.89

167.14

97.71

-513.01

19.66

38.08

252.08*

289.16

ATC-N

 Level change

1666.28

-5302.76***

-1251.70***

-3423.59

-87.38

-6.54

-2606.62**

-2699.69**

 Trend change

41.47

207.32**

-34.97

16.70

-2.87

-0.29

229.84

227.88

ATC-J

 Level change

-364.30**

-5386.60***

-1170.61***

-7234.71***

-0.46

-570.38*

-426.63

-1070.85

 Trend change

24.60

76.77

-81.64**

-229.26

10.84

85.81*

185.61**

282.27**

ATC-L

 Level change

5610.89***

-10,100.00***

-830.18*

-5107.80*

-

-87.39

-236.16

-336.03

 Trend change

136.23

96.98

100.62

-51.36

-

91.62***

-209.49*

-116.85

Others

 Level change

2305.78***

-4927.85***

-13,900.00***

-14,100.00***

-

-

-1031.71

-1031.71

 Trend change

163.79**

94.84

-17.68

-397.73

-

-

99.82

99.82

  1. ***p-value < 0.001
  2. **p-value < 0.01
  3. *p-value < 0.05
  4. “Others” included ATC-A, ATC-B, ATC-M and ATC-R, due to the number of drugs in these categories extremely low